GlassScriptPhysician profile
Robyn Guinto
NPI 1285155911
$6,498.44
in general payments reported to CMS, 2019-2025
11 companies · $3,542 in 2025
The $3,542 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $154 · 2024: $2,803 · 2025: $3,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,223 · Travel and Lodging: $3,017 · Education: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,223.07 |
| Travel and Lodging | $3,016.52 |
| Education | $258.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,094.17 | 2024-2025 | General - Vascular Intervention, Eluvia, General - Therapies |
| Cook Incorporated | $783.60 | 2024 | Zenith |
| Cook Medical LLC | $760.47 | 2024-2025 | Zenith, Zenith Spiral-Z |
| Medtronic, INC. | $487.39 | 2023-2024 | Endurant Iis |
| Penumbra, INC. | $463.59 | 2024-2025 | Indigo System |
| W. L. Gore & Associates, INC. | $409.38 | 2024 | Gore Viabahn Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Shockwave Medical, INC | $155.00 | 2025 | |
| Abbott Laboratories | $148.91 | 2025 | Esprit |
| Bard Peripheral Vascular, INC. | $145.94 | 2024 | Venovo |
| Silk Road Medical, INC. | $25.56 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Acera Surgical, INC. | $24.43 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Guinto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.